Patents Assigned to Ambi, Inc.
  • Patent number: 6713469
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: March 30, 2004
    Assignee: Ambi Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6569830
    Abstract: Co-administration of a lysostaphin or other anti-staphylococcal agent which cleaves cross-links of peptidoglycans of staphylococci cell walls such as lysostaphin and an antibiotic effective against staphylococci due to antibiotic activity mediated by cell-wall activity is effective against staphylococcal infection, even staphylococci that may be resistant to one or other of lysostaphin or the cell-wall active antibiotic. Co-administration simultaneously suppresses the generation of antibiotic-resistant mutant strains. Effective cell-wall active antibiotics include &bgr;-lactams and glycopeptides.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: May 27, 2003
    Assignee: Ambi, Inc.
    Inventors: Michael Climo, Ellen Murphy, Gordon Archer
  • Patent number: 6471998
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: October 29, 2002
    Assignee: Ambi, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6432942
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: August 13, 2002
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6323192
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: November 27, 2001
    Assignee: Ambi Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6251888
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: June 26, 2001
    Assignee: Ambi, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6251889
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: June 26, 2001
    Assignee: AMBI, Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6156332
    Abstract: The invention relates to methods and compositions for masking the taste of minerals in ingestible products. In particular, tannic acid glycyrrhizin and acesulfame potassium are added to compostions comprising minerals such as potassium, calcium, magnesium, iron, copper, chromium, zinc and mixtures in order to reduce or eliminate the unpleasant taste or aftertase associated with these minerals.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: December 5, 2000
    Assignee: AMBI, Inc.
    Inventors: Abraham I. Bakal, Margaret A. Snyder
  • Patent number: 6143301
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: November 7, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6136317
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: October 24, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6100251
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: August 8, 2000
    Assignee: Ambi Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6100250
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: August 8, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6093711
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: July 25, 2000
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 6028051
    Abstract: Lysostaphin is an effective antibiotic in the treatment of staphylococcal infection. Large doses of lysostaphin or lysostaphin analogues are effective in short course, or even one dose administrations, in treating and eradicating staphylococcal infections, including those resistant to conventional antibiotics.
    Type: Grant
    Filed: August 27, 1998
    Date of Patent: February 22, 2000
    Assignee: Ambi Inc.
    Inventors: Michael W. Climo, Gordon L. Archer, Beth P. Goldstein
  • Patent number: 5985823
    Abstract: The invention is directed to methods of treating diseases brought on by infection of the colon by C. difficile and also by colonization of vancomycin-resistant enterococci; the methods employ nisin and other lanthionine-containing bacteriocins (lanthocins) as active agents.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: November 16, 1999
    Assignee: Ambi Inc.
    Inventor: Beth P. Goldstein
  • Patent number: 5980905
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: November 9, 1999
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 5948772
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions may further comprise at least one of a cyclooxygenase inhibitor, an acid and a mucolytic. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: September 7, 1999
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
  • Patent number: 5914326
    Abstract: A method for promoting weight and fat loss comprising administering to an individual in need thereof hydroxycitrate, carnitine and an agent which promotes the rapid intramitochondrial generation of oxaloacetate or induces endogenous production of pyruvate. This method also promotes an increase in lean body mass.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: June 22, 1999
    Assignee: AMBI Inc.
    Inventors: Mark F. McCarty, John Gustin
  • Patent number: 5910479
    Abstract: The invention concerns methods for killing antibiotic-resistant pathogenic bacteria which cause disease in humans and animals. In particular, the methods are directed to the killing of antibiotic-resistant or multi-drug resistant Streptococcus pneumoniae bacterial strains. The methods employ a lanthocin such as nisin or a variant thereof as bactericidal agent.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: June 8, 1999
    Assignee: AMBI Inc.
    Inventor: Beth P. Goldstein
  • Patent number: 5905075
    Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions may further comprise at least one of a cyclooxygenase inhibitor, an acid and a mucolytic. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: May 18, 1999
    Assignee: AMBI Inc.
    Inventors: Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth